Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case Report

Major Durable Response of Pembrolizumab in Chemotherapy Refractory Small Cell Bladder Cancer: A Case Report

Small cell carcinoma of the urinary bladder is a rare subtype (incidence of 1–9/1,000,000), characterized by an aggressive behavior with early metastasis and poor prognosis. Chemotherapy, radiation, and surgery are the usual treatment options, but to date, no accepted standard treatment exists. Sinc...

Full description

Bibliographic Details
Main Authors: Olav Toai Duc Nguyen, Stein Harald Sundstrøm, Ganna Surzhykova Westvik, Ane Karoline Stræte Røttereng, Mona Røli Melhus, Cecilie Bergseth, Elisabeth Kvelstad Hallem, Oluf Dimitri Røe
Format: Article
Language:English
Published: Karger Publishers 2020-09-01
Series:Case Reports in Oncology
Subjects:
immunotherapy
small cell bladder carcinoma
small cell carcinoma
liver metastasis
biomarkers
Online Access:https://www.karger.com/Article/FullText/509747

Internet

https://www.karger.com/Article/FullText/509747

Similar Items